Last updated on August 2019

An Observational Study of Herceptin SC Safety in Breast Cancer


Brief description of study

This is a phase IV, prospective, multicenter, observational study (regulatory post-marketing surveillance) in approximately 600 patients who are to receive Herceptin SC (trastuzumab, subcutaneous administration) per approved local labeling. Patients will be under observation according to standard of care in Korea.

Clinical Study Identifier: NCT02305628

Find a site near you

Start Over

Inje University, Sanggye-Paik Hospital

Seoul, Korea, Republic of
1.92miles
  Connect »

Gangnam Severance Hospital

Seoul, Korea, Republic of
1.92miles
  Connect »

ChungAng University Hospital

Seoul, Korea, Republic of
1.92miles
  Connect »

Ewha Womans University Mokdong Hospital

Seoul, Korea, Republic of
1.92miles
  Connect »

Borame Medical Center

Seoul, Korea, Republic of
4.3miles
  Connect »

Kangbuk Samsung Hospital

Seoul, Korea, Republic of
4.3miles
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
4.3miles
  Connect »

Miz Medi Hospital

Seoul, Korea, Republic of
4.3miles
  Connect »